SOCIEDADE BENEF ISRAELITABRAS HOSPITAL ALBERT EINSTEIN
🇧🇷Brazil
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1971-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.einstein.br
Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 30
- Registration Number
- NCT06154486
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, Sao Paulo, Brazil
Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT
Not Applicable
Completed
- Conditions
- Hematopoietic Stem Cell TransplantationBone Marrow Transplantation
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 35
- Registration Number
- NCT06118853
- Locations
- 🇧🇷
Maria Ester Azevedo Massola, São Paulo, SP, Brazil
Expansion of Virus-Specific Lymphocytes for Cell Therapy
Phase 1
Recruiting
- Conditions
- CMVCMV Viremia
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 10
- Registration Number
- NCT06011486
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
Evaluation of the Clinical Impact of Different Telemedicine Practices in Intensive Care Units
Not Applicable
Not yet recruiting
- Conditions
- TelemedicineCritical CareIntensive Care Units
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 25000
- Registration Number
- NCT05960994
Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension
Phase 3
Recruiting
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2023-06-27
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 698
- Registration Number
- NCT05920005
- Locations
- 🇧🇷
Hospital de Urgência e Emergência de Rio Branco, Rio Branco, AC, Brazil
🇧🇷Centro de Pesquisas Clinicas Dr. Marco Mota (Centro Universitario Cesmac/ Hospital do Coração de Alagoas), Maceió, Alagoas, Brazil
🇧🇷Centro de Pesquisas em Diabetes e Doenças Endócrino Metabólicas LTDA, Fortaleza, Ceará, Brazil
Patients Undergoing Continuous Venovenous Hemodiafiltration: Effects of Increased Blood Flow
Not Applicable
Active, not recruiting
- Conditions
- Acute Kidney Injury
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 27
- Registration Number
- NCT05796661
- Locations
- 🇧🇷
Hospital Israelite Albert Einstein, São Paulo, Brazil
Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
Recruiting
- Conditions
- MonkeypoxMPOX
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 80
- Registration Number
- NCT05784038
- Locations
- 🇧🇷
Hospital Universitário João de Barros Barreto, Belem, Para, Brazil
🇧🇷Hospital Israelita Albert Einstein, São Paulo, Sao Paulo, Brazil
🇧🇷Hospital Naval Marcílio Dias, Rio De Janeiro, Brazil
Platelet Sub-study of the Neomindset Trial
Phase 4
Active, not recruiting
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2023-03-14
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 48
- Registration Number
- NCT05767723
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, Brazil
A Phase I Clinical Trial Using Genetically Engineered Autologous T Cells to Express Chimeric Antigen Receptor (CAR) for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
Phase 1
Not yet recruiting
- Conditions
- Acute Lymphoblastic Leukemia RefractoryB-cell Lymphoma RefractoryB-cell Lymphoma RecurrentAcute Lymphoblastic Leukemia, in RelapseChronic Lymphocytic Leukemia RecurrentChronic Lymphocytic Leukemia Refractory
- Interventions
- Biological: Chimeric antigen receptor T cells to be implemented in a "3 + 3" design on day 0
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 30
- Registration Number
- NCT05705570
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, Brazil
Use of Low-level Laser Therapy in the Treatment of Incontinence-associated Dermatitis in the Elderly
Not Applicable
Completed
- Conditions
- Dermatitis
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 16
- Registration Number
- NCT05699122
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, Brazil